News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
528,700 Results
Type
Article (30012)
Company Profile (93)
Press Release (498595)
Multimedia
Podcasts (42)
Webinars (10)
Section
Business (149248)
Career Advice (850)
Deals (25688)
Drug Delivery (63)
Drug Development (56681)
Employer Resources (71)
FDA (13501)
Job Trends (10906)
News (250597)
Policy (23498)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (1917)
Accelerated approval (29)
Adcomms (12)
Allergies (140)
Alliances (34662)
ALS (147)
Alzheimer's disease (1209)
Antibody-drug conjugate (ADC) (279)
Approvals (13986)
Artificial intelligence (462)
Autoimmune disease (204)
Automation (20)
Bankruptcy (213)
Best Places to Work (8604)
BIOSECURE Act (5)
Biosimilars (111)
Biotechnology (64)
Bladder cancer (161)
Brain cancer (51)
Breast cancer (545)
Cancer (4229)
Cardiovascular disease (334)
Career advice (753)
Career pathing (19)
CAR-T (197)
CDC (34)
Celiac Disease (3)
Cell therapy (547)
Cervical cancer (37)
Clinical research (51133)
Collaboration (1300)
Company closure (1)
Compensation (680)
Complete response letters (31)
COVID-19 (1748)
CRISPR (52)
C-suite (897)
Cystic fibrosis (83)
Data (6032)
Decentralized trials (2)
Denatured (24)
Depression (136)
Dermatology (68)
Diabetes (416)
Diagnostics (5084)
Digital health (40)
Diversity (7)
Diversity, equity & inclusion (23)
Drug discovery (160)
Drug pricing (105)
Drug shortages (26)
Duchenne muscular dystrophy (183)
Earnings (65033)
Editorial (37)
Employer branding (12)
Employer resources (72)
Events (81118)
Executive appointments (902)
FDA (16567)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (13)
Frontotemporal dementia (24)
Funding (1147)
Gene editing (109)
Generative AI (29)
Gene therapy (418)
GLP-1 (695)
Government (3372)
Grass and pollen (4)
Guidances (328)
Healthcare (14920)
HIV (55)
Huntington's disease (31)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (62)
Immunology and inflammation (123)
Immuno-oncology (58)
Indications (147)
Infectious disease (1942)
Inflammatory bowel disease (149)
Inflation Reduction Act (8)
Influenza (71)
Intellectual property (158)
Interviews (92)
IPO (11968)
IRA (24)
Job creations (2578)
Job search strategy (680)
JPM (22)
Kidney cancer (16)
Labor market (50)
Layoffs (278)
Leadership (16)
Legal (5183)
Liver cancer (78)
Longevity (14)
Lung cancer (615)
Lymphoma (330)
Machine learning (32)
Management (24)
Manufacturing (531)
MASH (140)
Medical device (13901)
Medtech (14015)
Mergers & acquisitions (14617)
Metabolic disorders (1008)
mRNA (89)
Multiple sclerosis (126)
NASH (13)
Neurodegenerative disease (258)
Neuropsychiatric disorders (64)
Neuroscience (2255)
NextGen: Class of 2026 (4788)
Non-profit (3278)
Now hiring (47)
Obesity (420)
Opinion (137)
Ovarian cancer (174)
Pain (196)
Pancreatic cancer (216)
Parkinson's disease (244)
Partnered (25)
Patents (312)
Patient recruitment (554)
Peanut (50)
People (48492)
Pharmaceutical (25)
Pharmacy benefit managers (18)
Phase 1 (15077)
Phase 2 (22362)
Phase 3 (17734)
Pipeline (6747)
Policy (156)
Postmarket research (1908)
Preclinical (5273)
Press Release (69)
Prostate cancer (244)
Psychedelics (36)
Radiopharmaceuticals (256)
Rare diseases (671)
Real estate (4034)
Recruiting (27)
Regulatory (18962)
Reports (28)
Research institute (1825)
Resumes & cover letters (108)
Rett syndrome (34)
RNA editing (11)
RSV (49)
Schizophrenia (151)
Series A (182)
Series B (138)
Service/supplier (3)
Sickle cell disease (63)
Special edition (9)
Spinal muscular atrophy (123)
Sponsored (23)
Startups (2619)
State (1)
Stomach cancer (12)
Supply chain (79)
Tariffs (33)
The Weekly (18)
Vaccines (623)
Venture capital (42)
Weight loss (268)
Women's health (83)
Worklife (5)
Date
Today (64)
Last 7 days (644)
Last 30 days (2429)
Last 365 days (21405)
2026 (8790)
2025 (21645)
2024 (25892)
2023 (29948)
2022 (39537)
2021 (42694)
2020 (41183)
2019 (35076)
2018 (26759)
2017 (24151)
2016 (23171)
2015 (27831)
2014 (21486)
2013 (17902)
2012 (19262)
2011 (19780)
2010 (18595)
Location
Africa (497)
Alabama (43)
Alaska (4)
Arizona (243)
Arkansas (12)
Asia (31109)
Australia (4845)
California (9004)
Canada (3071)
China (1053)
Colorado (407)
Connecticut (395)
Delaware (325)
Europe (64656)
Florida (1431)
Georgia (306)
Hawaii (2)
Idaho (47)
Illinois (823)
India (61)
Indiana (507)
Iowa (15)
Japan (459)
Kansas (105)
Kentucky (41)
Louisiana (35)
Maine (82)
Maryland (1179)
Massachusetts (6371)
Michigan (273)
Minnesota (608)
Mississippi (6)
Missouri (112)
Montana (29)
Nebraska (27)
Nevada (112)
New Hampshire (81)
New Jersey (2861)
New Mexico (16)
New York (2504)
North Carolina (1276)
North Dakota (8)
Northern California (4538)
Ohio (296)
Oklahoma (15)
Oregon (32)
Pennsylvania (1991)
Puerto Rico (18)
Rhode Island (39)
South America (738)
South Carolina (79)
Southern California (3535)
Tennessee (175)
Texas (1548)
United States (33583)
Utah (315)
Virginia (235)
Washington D.C. (57)
Washington State (655)
West Virginia (4)
Wisconsin (128)
Wyoming (2)
528,700 Results for "profound medical corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
·
5 min read
Press Releases
Profound Medical Reports Strong First Quarter 2026 Financial Results
May 8, 2026
·
14 min read
Press Releases
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
April 16, 2026
·
2 min read
Press Releases
Profound Medical Announces Upcoming Investor Events
January 28, 2026
·
2 min read
Press Releases
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
May 14, 2026
·
8 min read
Press Releases
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
March 5, 2026
·
19 min read
Press Releases
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
April 1, 2026
·
7 min read
Press Releases
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
March 15, 2026
·
10 min read
Press Releases
Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
February 12, 2026
·
6 min read
Press Releases
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
February 12, 2026
·
2 min read
1 of 52,870
Next
